Is ZSAN or RYLD a better dividend investment in 2026?

ZSAN currently yields 358.68% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: ZSAN offers higher current income.

What is the dividend yield difference between ZSAN and RYLD?

ZSAN has a forward dividend yield of 358.68% ($2.00/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 346.29 percentage points.

Home › Compare › ZSAN vs RYLD

ZSAN vs RYLD: Dividend Comparison 2026

ZSAN yields 358.68% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ZSAN wins by $5209.15M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ZSAN

● Live price

358.68%

Share price

$0.56

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$5209.20M

Annual income

$3,364,155,661.75

Full ZSAN calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — ZSAN vs RYLD

📍 ZSAN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ZSAN	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ZSAN + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ZSAN pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZSAN

Annual income on $10K today (after 15% tax)

$30,487.80/yr

After 10yr DRIP, annual income (after tax)

$2,859,532,312.49/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, ZSAN beats the other by $2,859,530,031.95/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZSAN + RYLD for your $10,000?

ZSAN: 50%RYLD: 50%

100% RYLD50/50100% ZSAN

Portfolio after 10yr

$2604.62M

Annual income

$1,682,079,172.36/yr

Blended yield

64.58%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ZSAN right now

ZSAN

Analyst Ratings

Buy

Hold

Consensus: Buy

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZSAN buys

RYLD buys

No recent congressional trades found for ZSAN or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricZSANRYLD

Forward yield	358.68% ✓	12.39%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$5209.20M ✓	$45.3K
Annual income after 10y	$3,364,155,661.75 ✓	$2,682.98
Total dividends collected	$5034.10M ✓	$19.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ZSAN vs RYLD ($10,000, DRIP)

Year	ZSAN Portfolio	ZSAN Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$46,568	$35,868.01	$11,939	$1,239.34	+$34.6K → ZSAN
2	$205,931	$156,102.94	$14,158	$1,382.89	+$191.8K → ZSAN
3	$865,496	$645,150.13	$16,682	$1,532.59	+$848.8K → ZSAN
4	$3,460,164	$2,534,083.72	$19,537	$1,687.64	+$3.44M → ZSAN
5	$13,170,607	$9,468,231.28	$22,752	$1,847.20	+$13.15M → ZSAN
6	$47,774,260	$33,681,710.63	$26,355	$2,010.43	+$47.75M → ZSAN
7	$165,300,693	$114,182,234.19	$30,376	$2,176.45	+$165.27M → ZSAN
8	$546,100,449	$369,228,707.89	$34,847	$2,344.43	+$546.07M → ZSAN
9	$1,724,339,796	$1,140,012,314.98	$39,800	$2,513.54	+$1724.30M → ZSAN
10	$5,209,199,243	$3,364,155,661.75	$45,269	$2,682.98	+$5209.15M → ZSAN

ZSAN vs RYLD: Complete Analysis 2026

ZSAN — Stock

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. On June 1, 2022, Zosano Pharma Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Full ZSAN Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this ZSAN vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZSAN vs SCHD ZSAN vs JEPI ZSAN vs O ZSAN vs KO ZSAN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.